DavidAlanFrankMD

Hematologic Oncology

Director of the Division of Hematology, Professor of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute

Join to view full profile

Dr. Frank is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Frank's full profile

Already have an account?

Office
1364 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-778-6510

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1993
Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
Yale School of MedicineClass of 1986

Certifications & Licensure

GA State Medical License 2021 - 2026
MA State Medical License 1990 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2002

Publications & Presentations

PubMed

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes.
Zoe King, Sudhamsh Reddy Desai, David A Frank, Aditi Shastri
Neoplasia. 2025-02-10
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.
Hazel Ozuna, Dinesh Bojja, Santiago Partida-Sanchez, Luanne Hall-Stoodley, Amal Amer
Frontiers in Immunology. 2025-01-01
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.
Michael J Hochman, David A Frank
Clinical Cancer Research. 2024-10-15

Journal Articles

Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma Xenografts
David A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature

Abstracts/Posters

Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
David A. Frank, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Covid-19 AI Update: NIH Developing Imaging ToolsAugust 13th, 2020
Cancer Care Patients and Families Prioritize High-Quality Relationships and CommunicationSeptember 21st, 2017
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckNovember 9th, 2016

Grant Support

Dual Stat3/Nf-Kb Inhibitors For Targeted Cancer TherapyNational Cancer Institute2012
STAT3 In The Pathogenesis And Treatment Of Pancreatic CancerNational Cancer Institute2006–2007
High Throughput Screening For Modulators Of STAT5 (RMI)National Institute Of Neurological Disorders And Stroke2004
STAT Signaling In Chronic Lymphocytic LeukemiaNational Cancer Institute1999–2003